Director/PDMR Share Purchases

RNS Number : 9340O
Cambridge Cognition Holdings PLC
06 February 2023
 

6 February 2023

Cambridge Cognition Holdings Plc

("Cambridge Cognition", the "Company" or the "Group")

Director/PDMR Share Purchases

Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets digital solutions to assess brain health, was informed on 3 February 2023 of the following purchases of the Company's ordinary shares by Directors and P DMRs of the Company .

The purchases made on 3 February 2023 are detailed in the table below:

Director/PDMR

No. of Ordinary Shares purchased

Purchase price per Ordinary Share

Total no. of Ordinary Shares held

Percentage ownership of total issued share capital

Matthew Stork

13,500

£1.11

161,450

0.47%

Stephen Symonds

10,000

£1.11

32,950

0.10%

Steven Powell

10,000

£1.11

226,375

0.65%

Richard Bungay

10,000

£1.11

10,000

0.03%

Debra Leeves

10,000

£1.12

60,000

0.16%

 

Further information on the purchases is contained in the disclosure tables below.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

Cambridge Cognition Holdings Plc  

Matthew Stork, Chief Executive Officer  

Stephen Symonds, Chief Financial Officer 

 

Tel: 012 2381 0700  

press@camcog.com  

Panmure Gordon (UK) Limited (NOMAD and Joint Broker)  

Freddy Crossley / Emma Earl 

Rupert Dearden 

 

Tel: 020 7886 2500 

(Corporate Finance) 

(Corporate Broking) 

Dowgate Capital Limited (Joint Broker)  

David Poutney / James Serjeant 

 

Tel: 020 3903 7715  

 

IFC Advisory Ltd (Financial PR and IR)  

Tim Metcalfe / Graham Herring / Zach Cohen  

Tel: 020 3934 6630  

 

 

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit  www.cambridgecognition.com

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Stork

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01p each

 

 

GB00B8DV9647

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

   Price(s)

Volume(s)

£1.11

13,500

 

d)

Aggregated information

- Aggregated volume

- Price



13,500


£1.11

e)

Date of the transaction

3 February 2023

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Symonds

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01p each

 

 

GB00B8DV9647

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

   Price(s)

Volume(s)

£1.11

10,000

 

d)

Aggregated information

- Aggregated volume

- Price



10,000


£1.11

e)

Date of the transaction

3 February 2023

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Steven Powell

2

Reason for the notification

a)

Position/status

Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01p each

 

 

GB00B8DV9647

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

   Price(s)

Volume(s)

£1.11

10,000

 

d)

Aggregated information

- Aggregated volume

- Price



10,000


£1.11

e)

Date of the transaction

3 February 2023

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Bungay

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01p each

 

 

GB00B8DV9647

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

   Price(s)

Volume(s)

£1.11

10,000

 

d)

Aggregated information

- Aggregated volume

- Price



10,000


£1.11

e)

Date of the transaction

3 February 2023

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Debra Leeves

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01p each

 

 

GB00B8DV9647

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

   Price(s)

Volume(s)

£1.12

10,000

 

d)

Aggregated information

- Aggregated volume

- Price



10,000


£1.12

e)

Date of the transaction

3 February 2023

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUGCPUPWGMW
UK 100

Latest directors dealings